AEMD Stock Overview
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States.
Aethlon Medical, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.38|
|52 Week High||US$2.46|
|52 Week Low||US$0.38|
|1 Month Change||-25.19%|
|3 Month Change||-59.91%|
|1 Year Change||-83.98%|
|3 Year Change||-84.52%|
|5 Year Change||-98.25%|
|Change since IPO||-99.99%|
Recent News & Updates
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn RateAug 02
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn RateMar 18
We're Interested To See How Aethlon Medical (NASDAQ:AEMD) Uses Its Cash Hoard To GrowNov 09
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn RateMay 12
We're Hopeful That Aethlon Medical (NASDAQ:AEMD) Will Use Its Cash WiselyJan 27
|AEMD||US Medical Equipment||US Market|
Return vs Industry: AEMD underperformed the US Medical Equipment industry which returned -23.1% over the past year.
Return vs Market: AEMD underperformed the US Market which returned -20.6% over the past year.
|AEMD Average Weekly Movement||10.4%|
|Medical Equipment Industry Average Movement||8.8%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.6%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: AEMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: AEMD's weekly volatility (10%) has been stable over the past year.
About the Company
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer.
Aethlon Medical, Inc. Fundamentals Summary
|AEMD fundamental statistics|
Is AEMD overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|AEMD income statement (TTM)|
|Cost of Revenue||US$0|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.57|
|Net Profit Margin||-43,085.29%|
How did AEMD perform over the long term?See historical performance and comparison